Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | October 05, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date October 05, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 49,448 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Sale · Disposed 2,403 · Balance 49,448 F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934 |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 7, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 2,403 | $15.00 | $36,045.00 |
DisclosureSEC source: 0001628280-26-065349 · wk-form4_1791406827.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,448 F1 · kind: The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934 Read SEC document |
| August 24, 2026 Filed Aug 25, 2026 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 330 | $6.98 | $2,302.41 |
DisclosureSEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,851 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,975 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,296 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,181 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 21:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-058939 · wk-form4_1787691673.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 17, 2026 Filed Jul 20, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 752 | $7.90 | $5,943.06 |
DisclosureSEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,438 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,131 Underlying: Class A Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,883 Underlying: Class A Common Stock · 1,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 16, 2026 Filed Jul 20, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-048832 · wk-form4_1784581219.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 22, 2026 Filed May 26, 2026 21:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 307 | $8.33 | $2,558.54 |
DisclosureSEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,704 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 21, 2026 Filed May 26, 2026 21:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,443 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| May 21, 2026 Filed May 26, 2026 21:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,057 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| May 21, 2026 Filed May 26, 2026 21:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| May 21, 2026 Filed May 26, 2026 21:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-038202 · wk-form4_1779829445.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 324 | $7.95 | $2,576.45 |
DisclosureSEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,268 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,599 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,644 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:02 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-026038 · wk-form4_1776718959.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,436 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 13, 2026 Filed Apr 14, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 33,171 | $6.41 | $212,758.79 |
DisclosureSEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,849 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of PSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 45,553 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 45,553 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors. F4 · derivative.expiration_date: On May 21, 2025, in connection with the Reporting Person's elevation to Chief Financial Officer, the Reporting Person was granted 67,991 PSUs based on a company-wide cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 67% of the company-wide target, as certified by the Compensation Committee of the Board of Directors. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionPerformance-Based Restricted Stock Unit · Derivative | 28,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 28,368 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors. F3 · derivative.expiration_date: On March 6, 2025, the Reporting Person was granted 45,755 based on a finance team cash flow reduction target over a one-year period beginning on January 1, 2025 and ending on December 31, 2025. The total number of vested PSUs distributed by Issuer on April 10, 2026 in the form of Class A Common Stock reflects actual performance equal to 62% of the finance team target, as certified by the Compensation Committee of the Board of Directors. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 45,553 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| April 10, 2026 Filed Apr 14, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 28,368 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-025107 · wk-form4_1776200454.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 708 | $6.74 | $4,768.38 |
DisclosureSEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,099 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| March 13, 2026 Filed Mar 18, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,755 Underlying: Class A Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| March 13, 2026 Filed Mar 18, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,231 Underlying: Class A Common Stock · 1,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| March 13, 2026 Filed Mar 18, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| March 13, 2026 Filed Mar 18, 2026 21:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-019475 · wk-form4_1773867620.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 972 | $8.92 | $8,667.32 |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,321 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 7 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026. F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% vested on January 16, 2026. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 6 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,067 Underlying: Class A Common Stock · 156 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,405 Underlying: Class A Common Stock · 587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| January 16, 2026 Filed Jan 22, 2026 21:12 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-003084 · wk-form4_1769116333.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 736 | $8.89 | $6,540.10 |
DisclosureSEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,488 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,223 Underlying: Class A Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · derivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,992 Underlying: Class A Common Stock · 1,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:11 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-25-057441 · wk-form4_1765923061.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,312 | $13.65 | $17,907.49 |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 4 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,738 F2 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 7 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,062 Underlying: Class A Common Stock · 1,061 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026. F5 · derivative.expiration_date: The RSUs vest as follows: 25% vested on April 16, 2025; 25% vested on July 16, 2025; 25% vested on October 16, 2025; and 25% will vest on January 16, 2026. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 6 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,535 Underlying: Class A Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4 · derivative.exercise_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. F4 · derivative.expiration_date: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · derivative · entry 5 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,166 Underlying: Class A Common Stock · 1,174 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3 · derivative.exercise_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. F3 · derivative.expiration_date: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,061 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 3 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 2 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 16, 2025 Filed Oct 21, 2025 20:56 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,174 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001977441-25-000010 · wk-form4_1761080182.xml · nonDerivative · entry 1 Coen Steven P. · CIK 0001977441 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.